Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NeXstar, Becton, Dickinson deal

NXTR and Becton, Dickinson redefined the terms of their May 1993 agreement to develop in vitro diagnostic reagents using NXTR's SELEX

Read the full 212 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE